Rs 7 Dividend + 1:1 Bonus Issue: BSE smallcap firm declares double delight in Q2 result - Record date announced

Healthcare service provider, Dr Lal PathLabs Limited, announced its financial results for the quarter ended September 30, 2025, along with a major reward for shareholders, a second interim dividend and a bonus issue.

For the quarter (Q2 FY26), the company reported a 10.7 per cent year-on-year (YoY) increase in revenue to Rs 731 crore, compared to Rs 660 crore in the same period last year.

Dr Lal PathLabs Q2FY26 Highlights

Add Zee Business as a Preferred Source

EBITDA grew 10.8 per cent YoY to Rs 224 crore, with margins stable at 30.7 per cent, indicating strong cost management and operational efficiency.

Profit before tax (PBT) rose 11.2 per cent to Rs 204 crore, while net profit (PAT) came in at Rs 152 crore, up 16.4 per cent YoY from Rs 131 crore in Q2 FY25.

Earnings per share (EPS) improved to Rs 18.1 from Rs 15.5 a year earlier.

During the first half of FY26 (H1 FY26), the company continued its growth momentum, with revenue up 11 per cent YoY at Rs 1,400 crore and PAT rising 20 per cent to Rs 286 crore.

EBITDA for the half year stood at Rs 416 crore, up 11.8 per cent, with healthy margins of 29.7 per cent.

Dr Lal PathLabs Dividend

Alongside its solid financial performance, Dr Lal PathLabs’ Board declared a second interim dividend of Rs 7 per share (70 per cent on face value of Rs 10 each) for FY26.

Dr Lal PathLabs Dividend Record Date

The record date for this dividend is November 7, 2025, and the payout will be made within 30 days of declaration.

Dr Lal PathLabs Bonus Issue

Additionally, the company approved a 1:1 bonus issue, under which shareholders will receive one fully paid-up equity share for every one share held, subject to necessary approvals.

The record date for the bonus issue will be announced later.

Dr Lal PathLabs Dividend History

Dr Lal PathLabs has also demonstrated a strong history of shareholder rewards. Over the past year, it consistently paid Rs 6 per share as interim and final dividends on multiple occasions, in August 2025, June 2025, February 2025, November 2024, and August 2024.